Niobium and tantalum recovery from the primary source and from tin slag,an industrial challenge: A review

Niobium (Nb) and Tantalum (Ta) are used to increase materials' mechanical resistance and produce lighter alloys. Worldwide Nb production reached 78 000 t in 2020. The reduced ore offer justifies the recycling of these metals from tin slag, contributing to the circular economy. Nb₂O₅ and Ta₂O₅ extraction either from the primary source or the tin slag is an industrial challenge. Nb and Ta dissolution processes already implemented are fluoride leaching, sulphuric leaching, alkaline leaching, and alkaline roasting. The fluoride process raises environmental concerns about waste control. The sulphuric method can be managed to have higher Nb and Ta extraction in a less aggressive process, if some changes are implemented, such as increasing the number of extraction steps, decreasing the pulp density, or increasing the temperature; however, the efficiency of this methodology must be tested for tin slag. The alkaline method seems to be more selective to Nb and Ta by reactants and temperature control. Despite those well-established Nb and Ta treatments, they must be adapted to recover Nb and Ta from slag. The slag has low Nb and Ta content, while high Si and Ca concentrations exist in the matrix. This paper brings the main methods used to extract the Nb and Ta from the primary resources and an overview of Nb and Ta recovery from the slag. This investigation comes as a tool to guide the development of new methods to recover Nb and Ta from low-grade sources such as tin slag.     

Development of composite membrane PBAT: Zeolite Y for application as rhynchophorol release system

Composite membranes consisting of biodegradable poly(butylene adipate‐co‐terephthalate (PBAT) and zeolite Y (0–10 wt %) were produced by extrusion. Zeolite Y is well dispersed in the membrane up to 5 wt %, but tends to agglomerate at higher contents. The presence of zeolite Y in the composite resulted in an improvement of the thermal stability, mechanical properties, and increased the barrier properties. The interaction of the composite membranes with rhynchophorol was investigated by different techniques, showing that the semiochemical progressively lixiviates PBAT monomers, causing thermal and mechanical properties to decrease. However, no interaction seemed to occur between the rhynchophorol and the zeolite. Studies of diffusion of pheromone through membranes have shown that the addition of the zeolite Y has not contributed significantly to a decrease in the release rate of rhynchophorol, but the presence of the zeolite Y helps to increase chemical, mechanical, and thermal stabilities of the membranes. © 2017 Wiley Periodicals, Inc. J. Appl. Polym. Sci. 2018 , 135, 45757.     

Scleroderma-like Impairment in the Network of Telocytes/CD34+ Stromal Cells in the Experimental Mouse Model of Bleomycin-Induced Dermal Fibrosis

Considerable evidence accumulated over the past decade supports that telocytes (TCs)/CD34⁺ stromal cells represent an exclusive type of interstitial cells identifiable by transmission electron microscopy (TEM) or immunohistochemistry in various organs of the human body, including the skin. By means of their characteristic cellular extensions (telopodes), dermal TCs are arranged in networks intermingled with a multitude of neighboring cells and, hence, they are thought to contribute to skin homeostasis through both intercellular contacts and releasing extracellular vesicles. In this context, fibrotic skin lesions from patients with systemic sclerosis (SSc, scleroderma) appear to be characterized by a disruption of the dermal network of TCs, which has been ascribed to either cell degenerative processes or possible transformation into profibrotic myofibroblasts. In the present study, we utilized the well-established mouse model of bleomycin-induced scleroderma to gain further insights into the TC alterations found in cutaneous fibrosis. CD34 immunofluorescence revealed a severe impairment in the dermal network of TCs/CD34⁺ stromal cells in bleomycin-treated mice. CD31/CD34 double immunofluorescence confirmed that CD31⁻/CD34⁺ TC counts were greatly reduced in the skin of bleomycin-treated mice compared with control mice. Ultrastructural signs of TC injury were detected in the skin of bleomycin-treated mice by TEM. The analyses of skin samples from mice treated with bleomycin for different times by either TEM or double immunostaining and immunoblotting for the CD34/α-SMA antigens collectively suggested that, although a few TCs may transition to α-SMA⁺ myofibroblasts in the early disease stage, most of these cells rather undergo degeneration, and then are lost. Taken together, our data demonstrate that TC changes in the skin of bleomycin-treated mice mimic very closely those observed in human SSc skin, which makes this experimental model a suitable tool to (i) unravel the pathological mechanisms underlying TC damage and (ii) clarify the possible contribution of the TC loss to the development/progression of dermal fibrosis. In perspective, these findings may have important implications in the field of skin regenerative medicine.     

Rheological properties of aqueous α A12O3 suspensions: Influence of dispersant concentration

The effects of concentration of polyacrylic acid as a dispersant on rheological properties of aqueous alumina suspensions have been investigated under steady and oscillatory shear conditions. At solid volume fractions between 0.45 and 0.6, a high degree of particle stabilization is achieved when 0.2 wt% of polyacrylic acid is added. At lower dispersant concentrations, suspensions exhibit pronounced irreversible thixotropic behaviour, whereas at higher dispersant concentrations, time dependent effects on the flow properties are not detectable. When the saturation adsorption limit of the polyelectrolyte on Al₂O₃ is reached, further addition of the dispersant appreciably changes the flow behaviour, as well as the viscoelastic response of investigated suspensions. The data under steady shear are described by application of the generalized Casson model, and for the analysis of viscoelastic data the generalized Maxwell model is used.     

Crosstalk between Macrophages and Pancreatic β-Cells in Islet Development,Homeostasis and Disease

Macrophages are highly heterogeneous and plastic immune cells with peculiar characteristics dependent on their origin and microenvironment. Following pathogen infection or damage, circulating monocytes can be recruited in different tissues where they differentiate into macrophages. Stimuli present in the surrounding milieu induce the polarisation of macrophages towards a pro-inflammatory or anti-inflammatory profile, mediating inflammatory or homeostatic responses, respectively. However, macrophages can also derive from embryonic hematopoietic precursors and reside in specific tissues, actively participating in the development and the homeostasis in physiological conditions. Pancreatic islet resident macrophages are present from the prenatal stages onwards and show specific surface markers and functions. They localise in close proximity to β-cells, being exquisite sensors of their secretory ability and viability. Over the years, the crucial role of macrophages in β-cell differentiation and homeostasis has been highlighted. In addition, macrophages are emerging as central players in the initiation of autoimmune insulitis in type 1 diabetes and in the low-grade chronic inflammation characteristic of obesity and type 2 diabetes pathogenesis. The present work reviews the current knowledge in the field, with a particular focus on the mechanisms of communication between β-cells and macrophages that have been described so far.     

Elevated Circulating and Placental SPINT2 Is Associated with Placental Dysfunction

Biomarkers for placental dysfunction are currently lacking. We recently identified SPINT1 as a novel biomarker; SPINT2 is a functionally related placental protease inhibitor. This study aimed to characterise SPINT2 expression in placental insufficiency. Circulating SPINT2 was assessed in three prospective cohorts, collected at the following: (1) term delivery (n = 227), (2) 36 weeks (n = 364), and (3) 24–34 weeks’ (n = 294) gestation. SPINT2 was also measured in the plasma and placentas of women with established placental disease at preterm (<34 weeks) delivery. Using first-trimester human trophoblast stem cells, SPINT2 expression was assessed in hypoxia/normoxia (1% vs. 8% O2), and following inflammatory cytokine treatment (TNFα, IL-6). Placental SPINT2 mRNA was measured in a rat model of late-gestational foetal growth restriction. At 36 weeks, circulating SPINT2 was elevated in patients who later developed preeclampsia (p = 0.028; median = 2233 pg/mL vs. controls, median = 1644 pg/mL), or delivered a small-for-gestational-age infant (p = 0.002; median = 2109 pg/mL vs. controls, median = 1614 pg/mL). SPINT2 was elevated in the placentas of patients who required delivery for preterm preeclampsia (p = 0.025). Though inflammatory cytokines had no effect, hypoxia increased SPINT2 in cytotrophoblast stem cells, and its expression was elevated in the placental labyrinth of growth-restricted rats. These findings suggest elevated SPINT2 is associated with placental insufficiency.